MoonLake Immunotherapeutics

MoonLake Immunotherapeuticsverified

MLTX

Price:

$54.31

Market Cap:

$3.43B

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.[Read more]

Industry

Biotechnology

IPO Date

2020-10-20

Stock Exchange

NASDAQ

Ticker

MLTX

The ROE as of December 2024 (TTM) for MoonLake Immunotherapeutics (MLTX) is -15.89%

According to MoonLake Immunotherapeutics’s latest financial reports and current stock price. The company's current ROE is -15.89%. This represents a change of 296.17% compared to the average of -4.01% of the last 4 quarters.

MoonLake Immunotherapeutics (MLTX) Historical ROE (quarterly & annually)

How has MLTX ROE performed in the past?

The mean historical ROE of MoonLake Immunotherapeutics over the last ten years is 80.35%. The current -15.89% ROE has changed -119.77% with respect to the historical average. Over the past ten years (40 quarters), MLTX's ROE was at its highest in in the December 2021 quarter at 19.08%. The ROE was at its lowest in in the March 2022 quarter at -65.10%.

Quarterly (TTM)
Annual

Average

80.35%

Median

-3.67%

Minimum

-131.92%

Maximum

460.66%

MoonLake Immunotherapeutics (MLTX) ROE by Quarter and Year

Discovering the peaks and valleys of MoonLake Immunotherapeutics ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual ROE = 460.66%

Minimum Annual Increase = -570527.39%

Minimum Annual ROE = -131.92%

Quarterly (TTM)
Annual
YearROEChange
2023-7.26%-94.49%
2022-131.92%-128.64%
2021460.66%-570527.39%

MoonLake Immunotherapeutics (MLTX) Average ROE

How has MLTX ROE performed in the past?

The current ROE of MoonLake Immunotherapeutics (MLTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

107.16%

5-year avg

80.35%

10-year avg

80.35%

MoonLake Immunotherapeutics (MLTX) ROE vs. Peers

How is MLTX’s ROE compared to its peers?

MoonLake Immunotherapeutics’s ROE is less than Terns Pharmaceuticals, Inc. (0%), greater than Day One Biopharmaceuticals, Inc. (-32.76%), greater than Acumen Pharmaceuticals, Inc. (-22.40%), greater than Amylyx Pharmaceuticals, Inc. (-32.99%), greater than Aerovate Therapeutics, Inc. (-85.39%), greater than Enliven Therapeutics, Inc. (-90.19%), greater than Structure Therapeutics Inc. (-29.46%), greater than Compass Therapeutics, Inc. (-16.40%), greater than Ventyx Biosciences, Inc. (-32.37%), greater than Nuvalent, Inc. (-54.94%), greater than Cerevel Therapeutics Holdings, Inc. (-28.63%), greater than Travere Therapeutics, Inc. (-98.94%), greater than Arcellx, Inc. (-541.59%), greater than Akero Therapeutics, Inc. (-8.28%), greater than 89bio, Inc. (-32.52%), greater than Pliant Therapeutics, Inc. (-59.58%), greater than null (-48.91%),

Build a custom stock screener for MoonLake Immunotherapeutics (MLTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MoonLake Immunotherapeutics using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MoonLake Immunotherapeutics (MLTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MoonLake Immunotherapeutics or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is MoonLake Immunotherapeutics's ROE?

How is the ROE calculated for MoonLake Immunotherapeutics (MLTX)?

What is the highest ROE for MoonLake Immunotherapeutics (MLTX)?

What is the 3-year average ROE for MoonLake Immunotherapeutics (MLTX)?

What is the 5-year average ROE for MoonLake Immunotherapeutics (MLTX)?

How does the current ROE for MoonLake Immunotherapeutics (MLTX) compare to its historical average?